Europe Veterinary Vaccines Market 2022-2028
MARKET OUTLOOK
According to Triton Market Research’s report, the veterinary vaccines market in Europe is anticipated to advance at a CAGR of 7.06% from 2022 to 2028. Countries that form the region include the United Kingdom, Germany, Italy, France, Spain, and those in Rest of Europe.
Europe has the presence of dominant international veterinary pharmaceuticals players such as Hester Biosciences Ltd and Virbac SA, influencing the market. Moreover, with advancements in technology, innovation, and R&D, there is an increased demand for vaccines.
The United Kingdom has the largest livestock population within the region, and as a result, the government focuses on providing solutions to animal health-related problems. Additionally, major players deal in pet care products, leading to the increased production of vaccines. Such factors boost the demand for vaccines in the country.
On the other hand, Germany is the third-largest pork producer globally, owing to a high swine population. The country is positioned at the top regarding increasing animal disease. However, with the presence of the world’s largest player, Boehringer Ingelheim, there is a significant growth in the vaccine market in the country.
Similarly, France has a stronghold of market leaders such as Ceva Sante Animale and Virbac SA. Further, investments by leading players in the veterinary public health capabilities have significantly expanded the production capacity for vaccines. Such infrastructural developments lead to the growth of the market.
COMPETITIVE OUTLOOK
The top companies in the veterinary vaccines market include Phibro Animal Health, Vaxxinova GmbH, Elanco Animal Health Inc, Merck Animal Health, Zoetis Inc, and Virbac SA.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook